TOP stocks:

Microsoft

Apple

Shares of other companies:

Palantir Technologies

Annaly Capital Management

Riot Blockchain

JPMorgan

SentinelOne

AbbVie (ABBV) stock consensus forecasts for the month and 2024 - 2028.

Last update: 10/16/2024, 12:23 AM

Brief information about AbbVie Inc.

Ticker: ABBV

Sector: Healthcare

Closing price of the last trading day: $191.86

Last trading day: 10/15/2024

Analyst forecast price: $169.54

52-week high/low: $164.87 / $127.03

Shares of AbbVie Inc. are traded on the stock exchange under the ticker ABBV and belong to the "Healthcare" sector. The head office is currently located at: 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US. The market capitalization of AbbVie is $290 908 013 000. At the same time, the number of shares in circulation is 1 765 540 000. The company's earnings before interest, taxes and depreciation for last year (called EBITDA) was 27 993 000 000$. The company has a good profit. The PE ratio according to the latest reporting is at around 45.02. P/E shows the investor how many years his investment in this business pays off. That is, investments in AbbVie shares will pay off in about 46 years. A very long payback period of investments, shares should be considered not as an investment idea, but as a speculative one.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for AbbVie shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.

AbbVie stock forecast

For investing in AbbVie stock, the investor is interested in the long-term outlook. We have collected for you all the forecasts of world analysts for the shares of this company and combined them into one consensus forecast for 2024, 2025, 2026, 2027, 2028?

After studying the forecasts, we can answer the questions:

How much will one share of AbbVie cost in 2024, 2025, 2026, 2027, 2028?

What is the consensus analyst forecast for AbbVie stock?

Should you buy AbbVie stock short term or long term?

Should I sell AbbVie shares in 2024 or wait?

Should I buy AbbVie stock in 2024 or wait?

Where is the estimated entry/exit point in AbbVie stock?

But remember, these forecasts are not investment ideas. You are fully responsible for the decisions you make.

How is a forecast made?

We collect public data about AbbVie and analyst forecasts for AbbVie stock. Next, the algorithms calculate a weighted average forecast, removing extreme values. As a result, at the output we get an updated forecast, as close as possible to reality.

AbbVie daily forecast for a month

After collecting analysts' forecasts, we made one average daily forecast for AbbVie shares for the next month. Short-term forecasts are characterized by rather low accuracy due to many factors influencing them. But let's see what we got.

Below on the page is a graph of the consensus forecast for AbbVie stock for the next month. (30 days). The gray color on the chart shows the historical price of the stock. The turquoise color shows the price forecast with a possible range of fluctuations.

The maximum target price that AbbVie shares will reach in the next 30 days is $213.79. This is the upper limit of the target price range. This represents upside potential of 11.43% from current levels.

In turn, the minimum value that the price can reach in 30 days is $146.87. From the current price, the drop will be 30.64%.

Thus, on the monthly timeframe, a channel is formed with a resistance level of $213.79 and a support level of $146.87. The width of this channel is $66.92. Accordingly, according to the theory of technical analysis, a downward breakdown of the channel will open the way to $80. If the resistance level is broken, then the road to $281 per share of AbbVie will open.

What is the probability of exiting the channel up? Near the level of the upper border of the channel, the stock price will be traded for only 1 day. The chances of breaking through the resistance level of AbbVie shares in the next 30 days or in the next period are very small. It is worth considering that if stocks break through the $213.79 resistance level and try to gain a foothold above it, then in the future they will most likely test this level from above and if the $213.79 mark holds, then this will be a new channel with new goals.

How about testing the strength of the support level? The price will stay near the support level for 5 days. There is a good chance that the stock will break through the $146.87 support level.

In addition, the real future price of one AbbVie share can be both higher and lower than the target forecast price, but approximately in the range between the pessimistic and optimistic target price.

Forecast table for 30 days
Date	Target	Pes.	Opt.	Vol., %
Oct 18	190.25	181.92	194.47	6.90
Oct 19	186.83	178.08	195.46	9.76
Oct 20	177.97	173.91	184.27	5.96
Oct 21	167.51	161.58	172.03	6.47
Oct 22	168.71	165.17	176.41	6.80
Oct 23	169.32	166.78	176.84	6.03
Oct 24	168.41	165.88	171.13	3.17
Oct 25	168.41	161.74	172.25	6.50
Oct 26	162.14	156.69	168.17	7.33
Oct 27	163.79	157.01	169.00	7.64
Oct 28	154.75	148.63	161.81	8.87
Oct 29	151.69	146.87	155.97	6.20
Oct 30	153.33	147.90	158.20	6.97
Oct 31	154.80	148.48	157.31	5.94
Nov 01	153.50	146.87	159.30	8.47
Nov 02	162.43	155.61	165.26	6.20
Nov 03	170.42	164.19	175.03	6.60
Nov 04	169.50	162.79	172.25	5.81
Nov 05	170.22	162.45	178.08	9.62
Nov 06	167.76	161.83	171.19	5.79
Nov 07	165.45	159.49	169.82	6.47
Nov 08	165.35	159.70	173.09	8.39
Nov 09	173.88	170.44	179.93	5.57
Nov 10	184.00	180.80	189.30	4.70
Nov 11	191.51	182.78	195.65	7.04
Nov 12	202.77	199.85	205.20	2.68
Nov 13	204.23	199.33	213.79	7.25
Nov 14	193.08	185.90	197.37	6.17
Nov 15	195.86	191.63	200.44	4.60
Nov 16	195.27	190.00	204.65	7.71

AbbVie Stock Forecast 18 Oct.

Presumably, on 10/18/2024, the price of shares will be in the range of $181.92 - $194.47. A $12.56 range width can provide 6.90% volatility. The weighted average price of this range is at $190.25, which is $0.34 lower than the previous day's weighted average price.

AbbVie Stock Forecast 19 Oct.

Presumably, on 10/19/2024, the price of shares will be in the range of $178.08 - $195.46. A $17.38 range width can provide 9.76% volatility. The weighted average price of this range is at $186.83, which is $3.43 lower than the previous day's weighted average price.

AbbVie Stock Forecast 20 Oct.

Presumably, on 10/20/2024, the price of shares will be in the range of $173.91 - $184.27. A $10.36 range width can provide 5.96% volatility. The weighted average price of this range is at $177.97, which is $8.85 lower than the previous day's weighted average price.

AbbVie Stock Forecast 21 Oct.

Presumably, on 10/21/2024, the price of shares will be in the range of $161.58 - $172.03. A $10.45 range width can provide 6.47% volatility. The weighted average price of this range is at $167.51, which is $10.47 lower than the previous day's weighted average price.

AbbVie Stock Forecast 22 Oct.

Presumably, on 10/22/2024, the price of shares will be in the range of $165.17 - $176.41. A $11.24 range width can provide 6.80% volatility. The weighted average price of this range is at $168.71, which is $1.21 higher than the previous day's weighted average price.

AbbVie Stock Forecast 23 Oct.

Presumably, on 10/23/2024, the price of shares will be in the range of $166.78 - $176.84. A $10.06 range width can provide 6.03% volatility. The weighted average price of this range is at $169.32, which is $0.61 higher than the previous day's weighted average price.

AbbVie Stock Forecast 24 Oct.

Presumably, on 10/24/2024, the price of shares will be in the range of $165.88 - $171.13. A $5.25 range width can provide 3.17% volatility. The weighted average price of this range is at $168.41, which is $0.91 lower than the previous day's weighted average price.

AbbVie Stock Forecast 25 Oct.

Presumably, on 10/25/2024, the price of shares will be in the range of $161.74 - $172.25. A $10.51 range width can provide 6.50% volatility. The weighted average price of this range is at $168.41, which is $0.00 higher than the previous day's weighted average price.

AbbVie Stock Forecast 27 Oct.

Presumably, on 10/27/2024, the price of shares will be in the range of $157.01 - $169.00. A $11.99 range width can provide 7.64% volatility. The weighted average price of this range is at $163.79, which is $1.65 higher than the previous day's weighted average price.

AbbVie Stock Forecast 28 Oct.

Presumably, on 10/28/2024, the price of shares will be in the range of $148.63 - $161.81. A $13.18 range width can provide 8.87% volatility. The weighted average price of this range is at $154.75, which is $9.04 lower than the previous day's weighted average price.

AbbVie Stock Forecast 29 Oct.

Presumably, on 10/29/2024, the price of shares will be in the range of $146.87 - $155.97. A $9.10 range width can provide 6.20% volatility. The weighted average price of this range is at $151.69, which is $3.06 lower than the previous day's weighted average price.

AbbVie Stock Forecast 30 Oct.

Presumably, on 10/30/2024, the price of shares will be in the range of $147.90 - $158.20. A $10.30 range width can provide 6.97% volatility. The weighted average price of this range is at $153.33, which is $1.64 higher than the previous day's weighted average price.

AbbVie Stock Forecast 31 Oct.

Presumably, on 10/31/2024, the price of shares will be in the range of $148.48 - $157.31. A $8.82 range width can provide 5.94% volatility. The weighted average price of this range is at $154.80, which is $1.47 higher than the previous day's weighted average price.

AbbVie Stock Forecast 01 Nov.

Presumably, on 11/01/2024, the price of shares will be in the range of $146.87 - $159.30. A $12.43 range width can provide 8.47% volatility. The weighted average price of this range is at $153.50, which is $1.30 lower than the previous day's weighted average price.

AbbVie Stock Forecast 02 Nov.

Presumably, on 11/02/2024, the price of shares will be in the range of $155.61 - $165.26. A $9.65 range width can provide 6.20% volatility. The weighted average price of this range is at $162.43, which is $8.93 higher than the previous day's weighted average price.

AbbVie Stock Forecast 03 Nov.

Presumably, on 11/03/2024, the price of shares will be in the range of $164.19 - $175.03. A $10.84 range width can provide 6.60% volatility. The weighted average price of this range is at $170.42, which is $7.99 higher than the previous day's weighted average price.

AbbVie Stock Forecast 04 Nov.

Presumably, on 11/04/2024, the price of shares will be in the range of $162.79 - $172.25. A $9.46 range width can provide 5.81% volatility. The weighted average price of this range is at $169.50, which is $0.92 lower than the previous day's weighted average price.

AbbVie Stock Forecast 05 Nov.

Presumably, on 11/05/2024, the price of shares will be in the range of $162.45 - $178.08. A $15.63 range width can provide 9.62% volatility. The weighted average price of this range is at $170.22, which is $0.71 higher than the previous day's weighted average price.

AbbVie Stock Forecast 06 Nov.

Presumably, on 11/06/2024, the price of shares will be in the range of $161.83 - $171.19. A $9.36 range width can provide 5.79% volatility. The weighted average price of this range is at $167.76, which is $2.45 lower than the previous day's weighted average price.

Table of forecasts for 2024.
Month	Target	Pes.	Opt.	Vol., %
Nov.	217.85	195.76	231.72	15.52
Dec.	241.92	234.06	258.27	9.38

Now let's look at the monthly consensus forecast for this year and beyond. The forecast is also based on the forecasts of world analysts, which are in the public domain. Forecasts for the year are medium-term and less dependent on external factors, and therefore more accurate than daily forecasts.

This year, the maximum possible price per AbbVie share is projected at $258.27. Peak forecasts from some agencies, which vary greatly in price, we have omitted.

The minimum levels for AbbVie shares for this year are $195.76.

Detailed forecast for 2024

Similarly, we calculated the consensus forecasts for the coming years, which are summarized in tables for convenience.

AbbVie (ABBV) Monthly Stock Prediction for 2025

Table of forecasts for 2025.
Month	Target	Pes.	Opt.	Vol., %
Jan	242.86	221.39	252.33	12.26
Feb	228.34	214.69	249.42	13.92
Mar	214.09	196.28	219.66	10.64
Apr	220.77	197.81	238.28	16.98
May	229.38	219.54	245.48	10.57
Jun	225.21	202.66	247.16	18.00
Jul	234.28	221.79	242.51	8.54
Aug	262.91	251.29	278.98	9.92
Sep	245.14	233.98	256.93	8.93
Oct	237.81	223.28	254.19	12.16
Nov	248.32	228.95	267.04	14.26
Dec	261.88	244.18	284.35	14.13

Detailed forecast for 2025

AbbVie (ABBV) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month	Target	Pes.	Opt.	Vol., %
Jan	274.47	253.07	301.59	16.09
Feb	308.37	279.11	338.44	17.53
Mar	305.97	278.52	327.45	14.94
Apr	307.96	299.15	334.78	10.64
May	301.15	281.18	316.03	11.03
Jun	273.35	264.47	291.12	9.15
Jul	275.13	252.96	302.67	16.43
Aug	289.44	261.59	318.41	17.84
Sep	276.27	268.73	288.84	6.96
Oct	303.56	284.23	311.85	8.86
Nov	338.69	329.88	372.15	11.36
Dec	317.11	303.09	341.43	11.23

Detailed forecast for 2026

AbbVie (ABBV) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month	Target	Pes.	Opt.	Vol., %
Jan	320.41	288.75	331.24	12.83
Feb	318.33	295.15	334.88	11.86
Mar	331.98	316.01	344.07	8.15
Apr	296.16	273.83	307.33	10.90
May	257.66	241.58	273.74	11.75
Jun	273.07	254.61	280.88	9.35
Jul	266.32	257.32	283.29	9.17
Aug	250.05	241.60	266.96	9.50
Sep	235.42	228.08	247.05	7.68
Oct	237.26	215.05	250.21	14.05
Nov	245.90	227.04	254.21	10.69
Dec	250.05	238.35	263.70	9.61

Detailed forecast for 2027

AbbVie (ABBV) Monthly Stock Prediction for 2028

Table of forecasts for 2028.
Month	Target	Pes.	Opt.	Vol., %
Jan	243.55	218.54	268.88	18.72
Feb	221.70	205.56	233.23	11.86
Mar	213.92	200.57	234.22	14.37
Apr	213.92	205.02	228.66	10.34
May	216.43	202.36	228.80	11.56
Jun	220.36	199.74	230.39	13.30
Jul	215.21	197.30	234.79	15.97
Aug	218.84	206.04	230.51	10.61
Sep	234.21	225.68	250.65	9.96
Oct	220.81	215.07	236.89	9.21
Nov	220.24	201.34	235.70	14.58
Dec	225.96	218.03	241.53	9.73

Detailed forecast for 2028

Stocks from the same sector (Healthcare)

Pfizer Inc. (PFE)

Moderna, Inc. (MRNA)

Waters Corp. (WAT)

UnitedHealth Group, Inc. (UNH)

AbbVie Inc. (ABBV)

Other securities